WEDNESDAY, Sept. 4, 2024 -- Current vaccines against mpox were designed to fight an older, rarer cousin of the virus, smallpox.Now, new research from...

KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...

Scientists have made a major breakthrough in neuroscience, developing a novel RNA-based nasal spray, COG-201, that has shown remarkable promise in...

A new MS drug Copaxone shows promise in reducing heart attack risk, offering potential benefits beyond multiple sclerosis for heart health and...

PharmAust’s breakthrough drug monepantel is generating buzz with its promising results in treating MND/ALS, potentially transforming the future for...

Though data from a mid-stage study shows that treatment with NBIX's schizophrenia drug is effective, results lag behind drugs being developed by its...

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....

Metronidazole is a standard treatment drug for Trichomoniasis; however, it has high breakthrough rate. Studies ongoing to change to alternate...

Researchers from the University of Massachusetts Amherst and UMass Chan Medical School have made a significant breakthrough in treating pancreatic...

Neurotech International has announced positive results of a genomic analysis conducted as part of its Phase 1/2 open-label clinical trial ...